Orange Book product · Generic (ANDA)
CHOLESTYRAMINE
CHOLESTYRAMINE
At a glance
Oct 19, 2021
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 19, 2021
4 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
CHOLESTYRAMINE
Strength
EQ 4GM RESIN/PACKET
Dosage form
POWDER
Route
ORAL
TE code
AB
Application
ANDA 211856
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CHOLESTYRAMINE
- 1988QUESTRAN LIGHTBrand (NDA)
NDA 019669 · BRISTOL MYERS
- —QUESTRANBrand (NDA)
NDA 016640 · BRISTOL MYERS
- 2026CHOLESTYRAMINEGeneric (ANDA)
ANDA 219318 · MICRO LABS
- 2024CHOLESTYRAMINEGeneric (ANDA)
ANDA 207294 · MACLEODS PHARMS LTD
- 2024CHOLESTYRAMINE LIGHTGeneric (ANDA)
ANDA 209109 · MACLEODS PHARMS LTD
- 2022CHOLESTYRAMINEGeneric (ANDA)
ANDA 214877 · AIPING PHARM INC
- 2021CHOLESTYRAMINE LIGHTGeneric (ANDA)
ANDA 211799 · ALKEM LABS LTD
- 2021CHOLESTYRAMINEGeneric (ANDA)
ANDA 209597 · PHARMOBEDIENT
- 2020CHOLESTYRAMINE LIGHTGeneric (ANDA)
ANDA 209599 · PHARMOBEDIENT CNSLTG
- 2020CHOLESTYRAMINEGeneric (ANDA)
ANDA 211119 · AJANTA PHARMA LTD
- 2018CHOLESTYRAMINEGeneric (ANDA)
ANDA 202901 · ZYDUS PHARMS
- 2017CHOLESTYRAMINE LIGHTGeneric (ANDA)
ANDA 202902 · ZYDUS PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
